Novo Nordisk has entered into a definitive agreement with Forma Therapeutics to buy all its outstanding shares, USD 20 per...
Merger and Acquisition
Good Therapeutics has entered into a merger agreement to be acquired by Roche to gain rights to the PD-1 regulated...
